Will Aklin

Will Aklin

Company: National Institute of Drug Abuse

Job title: Chief Clinical Research Grants Branch DTMC

Seminars:

Designing Clinical Trials & Leveraging Funding for Digital Therapeutics in Addiction 3:45 pm

Clinical trials focus on safety, efficacy, and relapse prevention using validated addiction endpoints NIDA supports digital therapeutic projects addressing opiates, smoking, vaping, and withdrawal-related insomnia Flagship funding opportunities to support projects aimed to scale and sustain innovative addiction treatmentsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.